Evidence map›Paper›PMID 24995108›Full record

ArticleInternational journal of clinical and experimental medicine2014

Relationship of ghrelin, acid uric and proinflammatory adipocytokines in different degrees of obesity or diabetes.

María Pilar Cruz-Domínguez, Daniel H Montes Cortés, Arturo Zarate, María de Los Ángeles Tapia-González, Sandra Alvarez-Acosta, Leticia Damasio, Leticia Manuel-Apolinar

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Increased Circulating Interleukin Concentrations in Type 2 Diabetes: A Systematic Review and Meta-Analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Lipocalin-2 plasmatic levels are reduced in patients with long-term type 2 diabetes mellitus.International journal of clinical and experimental medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

María Pilar Cruz-DomínguezDivisión de Investigación, Hospital de Especialidades, Centro Médico La Raza Mexico, DF, Mexico.
Daniel H Montes CortésDivisión de Investigación, Hospital de Especialidades, Centro Médico La Raza Mexico, DF, Mexico.
Arturo ZarateUnidad de Investigación Médica en Enfermedades Endocrinas, CMN, IMSS México, DF, México.
María de Los Ángeles Tapia-GonzálezEndocrinología, Hospital de Especialidades, Centro Médico La Raza Mexico, DF, Mexico.
Sandra Alvarez-AcostaDivisión de Investigación, Hospital de Especialidades, Centro Médico La Raza Mexico, DF, Mexico.
Leticia DamasioUnidad de Investigación Médica en Enfermedades Endocrinas, CMN, IMSS México, DF, México.
Leticia Manuel-ApolinarUnidad de Investigación Médica en Enfermedades Endocrinas, CMN, IMSS México, DF, México.
Hospital de Especialidades · MXMexican Social Security Institute · MXCentro Médico Nacional La Raza · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We compared and examined factors associated with ghrelin and uric acid in obese subjects (OB), obese plus type 2 diabetes mellitus (OBDM) and healthy controls (C). Methods. We analyzed blood count, renal function, liver enzymes, lipids, resistin, leptin, IL-6, uric acid and ghrelin in OB, OBDM and C. We included 76 subjects with different body mass index (BMI): 36 C (24 ± 3), 11 OB<40 (30-39.9), 20 OB>40 (40-60), and 9 OBDM (45.9 ± 9). Results. Metabolic profile was as follows: HOMA-IR 4.7 ± 3 and 5 ± 3 vs 2 ± 1 (p < 0.01), resistin 8.7 ± 2 and 9.4 ± 2 vs 5.4 ± 2 ng/mL (p < 0.001), leptin 6.2 ± 3.9 and 5.3 ± 2 vs 3.6 ± 1.8 ng/mL (p = 0.001) and IL-6 197.5 ± 78.9 and 223.6 ± 115 vs 7.4 ± 8.3 pg/mL (p = 0.001) in OB and OBDM vs C, respectively. Ghrelin was higher in OB<40 compared to C (1780 ± 197 vs 1465 ± 12 pg/mL, p < 0.05), and lower in OBDM (987.4 ± 114 pg/mL, p < 0.05). BMI showed a positive correlation with resistin (p < 0.001); leptin (p = 0.004), IL-6 (p = 0.001), uric acid (p = 0.0005) and negative with ghrelin (r = -0.431, p = 0.028). Resistin was directly correlated with leptin (p < 0.001) and inversely correlated with renal function (p = 0.03). Conclusion. Severe obesity and obesity-associated diabetes affected ghrelin and uric acid levels. This may well be associated with proinflammatory adipocytokines, insulin resistance, liver enzymes or renal function.

Indexed as

adipocytokinesdiabetesghrelinObesityuric acid

Identifiers

PMID24995108
PMCPMC4073769
OpenAlexW1669035004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.